BREAKING NEWS: Pfizer says booster shot of its COVID-19 vaccine extends protection and is being updated to target Indian ‘Delta’ variant
- Pfizer Inc and its German partner BioNTech says their COVID-19 booster shot extends protection against the disease
- Levels of neutralizing antibodies were five to 10 times higher than after the standard two doses
- The companies are planning to tailor their third dose to target the Indian ‘Delta’ variant directly
Clinical trials found that the third dose, given six months after the second should, generated levels of neutralizing antibodies five to 10 times higher than the initial two doses.
What’s more, the companies say they are planning to tweak the booster shot to target the Indian ‘Delta’ variant directly as it continues to spread across the U.S.
The companies said they plan to publish the data soon and submit it for approval to the U.S. Food and Drug Administration (FDA).
Pfizer Inc and its German partner BioNTech says their COVID-19 booster shot extends protection against the disease (file image)
This is a breaking news story and will be updated.